跳到正文
原文
Medical Xpress·· 2026-10-12AI 评分54

瑞典全国研究质疑叶酸补充降低自杀风险的作用,关联因性别和年龄而异

Study questions benefit of folic acid (vitamin B9) supplementation in reducing suicides

AI 导读

瑞典一项覆盖2006至2021年21个地区、涉及3463例20至29岁自杀相关死亡的观察性研究发现,叶酸处方与自杀死亡率的关联在性别和年龄间方向不一:20至24岁男性中较高的年度叶酸配发量与较高的自杀相关死亡率伴发,25至29岁男性则与自杀相关死亡减少伴发,女性中未见显著关联。

正文
taking supplement
Credit: Karola G from Pexels

Recent research has suggested that folic acid (vitamin B9) supplementation may reduce the risk of suicide attempts. However, a nationwide Swedish study, presented at the European College of Neuropsychopharmacology (ECNP) annual congress, raises doubts about the benefits of supplementation, as folic acid appears to affect different sexes and age groups differently.

Folic acid, also known as vitamin B9, plays an important role in the synthesis of neurotransmitters in the central nervous system. Folic acid status has been linked to depression, inflammation and suicidal behavior. In 2022, a large U.S. study published in JAMA Psychiatry reported that periods covered by folic acid prescriptions were associated with a 44% reduction in suicide attempts and episodes of intentional self-harm, leading to widespread interest in prescribing folic acid to vulnerable groups.

Associations differ by age and sex

The new Swedish study examined whether folic acid dispensing was associated with suicidality in young adults according to their age and sex. Researchers analyzed openly available nationwide data from all 21 Swedish regions over a 16-year period, from 2006 to 2021, including 3,463 suicide-related deaths among people ages 20–29. Of these deaths, 2,693 were classified as suicides and 770 as deaths from events of undetermined intent.

Among men, the results did not point in a single direction. Annual folic acid dispensing rates in men ages 20–24 were associated with a higher concentration of suicide-related deaths than in the younger age group. However, folic acid dispensing among men ages 25–29 was associated with a decrease in suicide-related deaths. No statistically significant associations were found among women.

"Our results should not be interpreted as evidence that folic acid increases suicide risk," said professor Jussi Jokinen of Karolinska Institutet and Umeå University, who led the study. "What they do suggest is caution. Observational associations between prescriptions and suicidal behavior can be difficult to interpret, because people who receive a treatment may differ in important ways from people who do not."

Prescriptions may reflect underlying health circumstances

The authors say the findings are particularly relevant because folic acid is inexpensive, widely available and biologically plausible as a suicide-reduction intervention. However, they emphasize that the Swedish study—like the 2022 JAMA paper—was observational, so the findings need to be put in context and treated with care. The present study compared regional patterns rather than following individual people who did or did not take folic acid. As a result, it cannot determine whether folic acid itself affected any individual's risk.

One possible explanation is "confounding by indication": folic acid is prescribed for a variety of reasons, and some of the medical, psychiatric or behavioral circumstances that lead to supplementation may themselves be linked to suicide risk. In that case, a folic acid prescription may sometimes be an indicator of underlying health circumstances rather than the cause of the observed outcome. These limitations mean the findings should be seen as a signal for further investigation, not as evidence for either a beneficial or harmful causal effect of folic acid supplementation.

Jokinen added, "Earlier work raised the important possibility that folic acid might be associated with reduced suicidal behavior. Our study does not directly contradict that work, because the populations, outcomes and study designs are different: it shows that the picture is not straightforward. Before folic acid can be discussed as a suicide-prevention strategy, we need individual-level longitudinal studies that can account for why it was prescribed and for patients' clinical characteristics. It means the jury is still out."

Clinical use unchanged pending closer study

Jokinen continued, "These findings should not prompt changes in the clinical use of folic acid. In particular, they should not be interpreted as evidence that folic acid increases suicide risk. Rather, they suggest that clinicians and researchers should be cautious about interpreting associations between folic acid prescriptions and suicidal outcomes as evidence of a direct protective effect.

"Our key next step is individual-level longitudinal research linking folic acid prescriptions to treatment indications, psychiatric and medical diagnoses, other medications, substance use and, ideally, biological folate measures. Such studies would help determine whether the observed associations reflect an effect of folic acid itself or characteristics of the patients for whom it is prescribed."

Moving beyond one-size-fits-all prevention

Commenting, Dr. Xenia Gonda (Semmelweis University, Budapest) said, "These findings of Jokinen's excellent study underline that suicidal behavior is not a single, biologically uniform phenomenon. Understanding its diverse neurobiological pathways—and how these may differ by sex and age—is essential if we are to identify new, more precisely targeted opportunities for prevention, including at the population level. This is particularly important for potential interventions such as folic acid, which is inexpensive, widely available, easy to use and free from the high thresholds and stigma often associated with accessing psychiatric care.

"At the same time, accessibility and biological plausibility do not establish efficacy. The authors are therefore right to emphasize that these observational findings cannot demonstrate either a causal role for folic acid in the development of suicidal behavior or a protective effect of supplementation. The observed sex- and age-related differences are especially valuable, as they highlight the need to move beyond one-size-fits-all models in both suicide research and psychiatric prevention."

Gonda was not involved in this work; this is an independent comment.

The study, "Association between folic acid prescription and suicide deaths among young adults in Sweden," will be presented by Jokinen, A. Mert and A. Desai Boström at the ECNP Congress in Munich. The authors are preparing a manuscript for submission to a peer-reviewed journal, so it has not yet been peer-reviewed.

Journal information: JAMA Psychiatry

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Study questions benefit of folic acid (vitamin B9) supplementation in reducing suicides (2026, October 11) retrieved 11 October 2026 from https://medicalxpress.com/news/2026-10-benefit-folic-acid-vitamin-b9.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com